TotalMarketCap

Evotec SE

EVONasdaq GermanyHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$626.130 M

$1.76 +12.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Evotec SE (EVO) has a market capitalization of $626.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

177,778,907

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #167Wave Life SciencesWVE$638.0M
  2. #168Zevra TherapeuticsZVRA$626.6M
  3. #169Evotec SEEVO$626.1M
  4. #170Design TherapeuticsDSGN$624.4M
  5. #171Obsidian TherapeuticsOBX$620.2M

What if Evotec SE were worth as much as…

Open the what-if tool →

Gold $28.2T

$79,371.56

Per share 45,097× higher

Bitcoin $1.53T

$4,294.66

Per share 2,440× higher

Apple $5.02T

$14,098.96

Per share 8,011× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Evotec SE are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.